In this paper, we show that FGF-BP knockdown exerts tumor-inhibiting effects in colon carcinoma in vitro and in vivo, which are based on anti-proliferative as well as pro-apoptotic effects in tumor cells. The gene discussed is FGFBP1; the disease is neoplasm.